Clinical Trial Update: Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine, carboplatin, and sorafenib in chemotherapy-naive patients with advanced/metastatic bladder cancer has completed with poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemcitabine (Gemcitabine)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Yale University | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-11-01